IM Cannabis Clinical Survey Reports Efficacy Of Its-Branded Stains For Conditions Such As PTSD, Insomnia, Back Pain, IBS
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) released promising results Thursday of a survey that evaluated the effectiveness of seven company-branded medical cannabis strains in treating seven health conditions.